既往剖宫产与后续冻融单倍体胚胎移植结局的关联
该回顾性队列研究纳入525例有活产史并接受自体冻融单倍体胚胎移植的女性,比较既往单次剖宫产与单次阴道分娩者的后续妊娠结局。校正混杂因素后,既往剖宫产与着床几率降低48%、持续妊娠及活产几率降低39%显著相关,而生化妊娠率与临床流产率无差异。
要点
- 既往剖宫产者冻融单倍体胚胎移植的着床率显著低于阴道分娩者。
- 校正混杂因素后,剖宫产史与着床、持续妊娠及活产几率降低独立相关。
- 生化妊娠率与临床流产率在两组间无显著差异。
核心结论
- 既往剖宫产与后续单倍体胚胎移植的着床率、持续妊娠及活产率显著降低相关。
研究设计与样本
- 单中心学术生育中心的回顾性队列研究,纳入2012年1月至2020年4月有活产史并接受自体冻融单倍体胚胎移植的女性,仅分析首个移植周期。
- 共525例患者符合标准,既往单次剖宫产者为病例组,既往单次阴道分娩者为对照组。
主要发现
- 剖宫产组体质指数高于阴道分娩组(24.5±4.5 vs 23.4±4.1;P=.004),其余人口学资料相似。
- 单变量分析中,剖宫产组着床率显著低于阴道分娩组(111/200 [55.5%] vs 221/325 [68.0%];P=.004)。
- 校正相关协变量后,既往剖宫产与着床几率降低48%相关(校正OR 0.52;95%CI 0.34-0.78;P=.002)。
- 校正相同协变量后,既往剖宫产与持续妊娠及活产几率降低39%相关(校正OR 0.61;95%CI 0.41-0.90;P=.01)。
- 生化妊娠率与临床流产率在两组间无差异。
关键数值与推荐
- 主要结局为着床率,次要结局包括持续妊娠及活产率、生化妊娠率和临床流产率。
- 仅纳入首个冻融单倍体胚胎移植周期。
临床怎么用
- 对有剖宫产史拟行冻融单倍体胚胎移植的患者,应告知其着床及活产几率可能降低。
- 临床咨询中可将剖宫产史作为影响移植结局的风险因素之一。
局限性
- 回顾性单中心设计可能引入选择偏倚和残余混杂。
- 剖宫产组体质指数显著更高,虽经校正但仍可能影响结果。
- 仅纳入单次剖宫产史且首个移植周期,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The rates of cesarean deliveries continue to increase worldwide. Previous work suggests an association between a previous cesarean delivery and reduced fertility in natural conception and in vitro fertilization treatment cycles. To our knowledge, there is no published research that explored the relationship between a previous cesarean delivery and the clinical outcomes after in vitro fertilization and the subsequent transfer of a single frozen-thawed euploid embryo. OBJECTIVE: This study aimed to investigate the relationship between the previous mode of delivery and subsequent pregnancy outcomes in patients undergoing a single frozen-thawed euploid embryo transfer after in vitro fertilization. STUDY DESIGN: A retrospective cohort study was performed at a single academic fertility center from January 2012 to April 2020. All women with a history of a live birth undergoing autologous, frozen-thawed single euploid embryo transfers were identified. Cases included patients with a single previous cesarean delivery; controls included patients with a single previous vaginal delivery. Only the first embryo transfer cycle was included. The primary outcome was the implantation rate. Secondary outcomes included ongoing pregnancy and live birth rates, biochemical pregnancy rate, and clinical miscarriage rate. RESULTS: A total of 525 patients met the inclusion criteria and were included in the analysis. Patients with a previous cesarean delivery had a higher body mass index (24.5±4.5 vs 23.4±4.1; P=.004) than those in the vaginal delivery cohort; the rest of the demographic data were otherwise similar. In a univariate analysis, the implantation rate was significantly lower in patients with a previous cesarean delivery (111/200 [55.5%] vs 221/325 [68.0%]; P=.004). After adjusting for the relevant covariates, a previous cesarean delivery was associated with a 48% reduction in the odds of implantation (adjusted odds ratio, 0.52; 95% confidence interval, 0.34-0.78; P=.002). In addition, after adjusting for the same covariates, a previous cesarean delivery was significantly associated with a 39% reduction in the odds of an ongoing pregnancy and live birth (adjusted odds ratio, 0.61; 95% confidence interval, 0.41-0.90; P=.01). There were no differences in the biochemical pregnancy rates or clinical miscarriage rates. CONCLUSION: This study demonstrated a marked reduction in implantation and ongoing pregnancy and live birth associated with a previous cesarean delivery in patients undergoing a single euploid embryo transfer. Our work stresses the importance of reducing the primary cesarean delivery rates at a national level and elucidating the mechanisms behind the substantially lower implantation rates after a cesarean delivery.
引用
- Friedenthal J, Alkon-Meadows T, Hernandez-Nieto C, et al. The association between prior cesarean delivery and subsequent in vitro fertilization outcomes in women undergoing autologous, frozen-thawed single euploid embryo transfer. Am J Obstet Gynecol. 2021. PMID: 33798478. doi:10.1016/j.ajog.2021.03.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。